An Australian doctor was charged today with endangering his patients' lives after police said he infected nearly 50 women with hepatitis C at an abortion clinic.

James Peters, 61, who worked as an anaesthesiologist at the Melbourne clinic, was charged with 54 counts of conduct endangering life, negligently causing serious injury and recklessly causing serious injury. The most serious charge carries a maximum sentence of 15 years in prison.

Peters was released on 250,000 Australian dollars bail when he appeared briefly at Melbourne Magistrates Court.

He was not required to enter pleas to the charges, which relate to 49 patients at the clinic who health officials say contracted the same strain of hepatitis C as Peters between 2008 and 2009.

Hepatitis C can cause serious liver problems, including cirrhosis and cancer. It is spread through the blood.

Police have not released details on how they believe the disease was transmitted. But Bram Alexander, a spokesman for the Victoria state Department of Health, said officials closely investigated all the infection control procedures at the clinic and did not find any problems.

"That's precisely why, back in early last year, we referred these matters to the police for further investigation - because our investigation could find no plausible reason as to why the infection took place," Mr Alexander said.

Peters had his registration suspended in February 2010.

Under his bail conditions Peters must not work in any medical- or health-related field and must not contact staff at a number of medical centres where he previously worked, including the abortion clinic. He was also required to surrender his passport.

Health chiefs tested more than 4,000 of Peters' patients during their investigation and found 49 who were infected with a strain of the virus genetically linked to his.

Sign up to our free newsletters

Get the best updates straight to your inbox:
Please select at least one mailing list.

You can unsubscribe at any time by clicking the link in the footer of our emails. We use Mailchimp as our marketing platform. By subscribing, you acknowledge that your information will be transferred to Mailchimp for processing.